Page last updated: 2024-09-04

levofloxacin and Gall Bladder Diseases

levofloxacin has been researched along with Gall Bladder Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW	1

Other Studies

1 other study(ies) available for levofloxacin and Gall Bladder Diseases

Article	Year
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010. International journal of antimicrobial agents, 2012, Volume: 40 Suppl Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gallbladder Diseases; Hospitalization; Humans; Levofloxacin; Liver Diseases; Microbial Sensitivity Tests; Ofloxacin; Population Surveillance; Practice Guidelines as Topic; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Taiwan; Time Factors	2012

Article

Year

Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.

International journal of antimicrobial agents, 2012, Volume: 40 Suppl

Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gallbladder Diseases; Hospitalization; Humans; Levofloxacin; Liver Diseases; Microbial Sensitivity Tests; Ofloxacin; Population Surveillance; Practice Guidelines as Topic; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Taiwan; Time Factors

2012